✦ LIBER ✦

Adalimumab Induces and Maintains Clinical Response and Remission in Patients With Active Crohn’s Disease: Results of the CHARM Trial

✍ Scribed by J. Colombel; W.J. Sandborn; P. Rutgeerts; R. Enns; S.B. Hanauer; P. Remo; S. Schreiber; K.G. Lomax; P.F. Pollack

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab for Maintenance of Clinical R

✍ Jean–Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Robert Enns; Stephe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Effect of adalimumab on clinical laborat

✍ David T. Rubin; Parvez Mulani; Jingdong Chao; Paul F. Pollack; Arielle G. Bensim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

Coherin™ peptides induce clinical respon

✍ Gary R Lichtenstein; Henry I Jacoby 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 37 KB

751e Adalimumab Induces and Maintains Mu

✍ Paul Rutgeerts; Geert R. D'Haens; Gert A. Van Assche; William J. Sandborn; Dougl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Adalimumab for the induction and mainten

✍ Mamoru Watanabe; Toshifumi Hibi; Kathleen G. Lomax; Susan K. Paulson; Jingdong C 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 813 KB

W1108 Remission, Response, and Quality-o

✍ Rutgeerts, Paul; Loftus, Edward V.; Binion, David G.; McHugh, Kevin; Chen, Naiju 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 124 KB